BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19009535)

  • 1. Comparison of Prenatal Risk Calculation (PRC) with PIA Fetal Database software in first-trimester screening for fetal aneuploidy.
    Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Corral A; Hillemanns P; Schmidt P
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):147-51. PubMed ID: 19009535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary analysis of the new 'Prenatal Risk Calculation (PRC)' software.
    Hörmansdörfer C; Scharf A; Golatta M; Vaske B; Hillemanns P; Schmidt P
    Arch Gynecol Obstet; 2009 Apr; 279(4):511-5. PubMed ID: 18704469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
    Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
    Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three-dimensional scatter plot analysis to estimate the risk of foetal aneuloidy].
    Schmidt P; Hörmansdörfer C; Oehler K; Härtel H; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2008 Aug; 212(4):127-35. PubMed ID: 18729035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to calculating the risk of chromosomal abnormalities with first-trimester screening data.
    Merz E; Thode C; Alkier A; Eiben B; Hackelöer BJ; Hansmann M; Huesgen G; Kozlowski P; Pruggmaier M; Wellek S
    Ultraschall Med; 2008 Dec; 29(6):639-45. PubMed ID: 19085755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to improve the screening and diagnosis of fetal aneuploidy?].
    Ville Y
    Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester combined screening for Down syndrome and other fetal anomalies.
    O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.
    Bianchi DW; Simpson JL; Jackson LG; Elias S; Holzgreve W; Evans MI; Dukes KA; Sullivan LM; Klinger KW; Bischoff FZ; Hahn S; Johnson KL; Lewis D; Wapner RJ; de la Cruz F
    Prenat Diagn; 2002 Jul; 22(7):609-15. PubMed ID: 12124698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined first trimester screening for trisomy 21: lack of agreement between risk calculation methods.
    Van Heesch PN; Schielen PC; Wildhagen MF; den Hollander K; Steegers EA; Wildschut HI
    J Perinat Med; 2006; 34(2):162-5. PubMed ID: 16519623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing first trimester screening performance: routine care gynaecologists' practices vs. prenatal centre.
    Kozlowski P; Knippel AJ; Stressig R
    Ultraschall Med; 2007 Jun; 28(3):291-5. PubMed ID: 17315110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential and contingent prenatal screening for Down syndrome.
    Wald NJ; Rudnicka AR; Bestwick JP
    Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining first and second trimester markers for Down syndrome screening: think twice.
    Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of current methods of prenatal screening for down syndrome].
    Hörmansdörfer C; Corral A; Scharf A; Vaske B; Hillemanns P; Schmidt P
    Rev Esp Salud Publica; 2010; 84(1):43-51. PubMed ID: 20376412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preference regarding first-trimester aneuploidy risk assessment.
    Sharma G; Gold HT; Chervenak FA; McCullough L; Alt AK; Chasen ST
    Am J Obstet Gynecol; 2005 Oct; 193(4):1429-36. PubMed ID: 16202737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.